Sultan Chowdhury - Xenon Pharmaceuticals Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 68 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery of Novel Cyclopentane Carboxylic Acids As Potent and Selective Inhibitors of NaV1.7

Shaoyi Sun,Sultan Chowdhury,Ivan Hemeon,Abid Hasan,Michael S. Wilson, Phillipe Bergeron,Qi Jia,Alla Y. Zenova,Mike E. Grimwood,Wei Gong,Shannon M. Decker,Paul Bichler,Jean-Christophe Andrez,Thilo Focken, Theresa Ngyuen, Jiuxiang Zhu,Andrew D. White,Girish Bankar, Sarah Howard,Elaine Chang,Kuldip Khakh

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2025)

Cited0Views0WOSBibtex

The Contribution of NaV1.6 to the Efficacy of Voltage-Gated Sodium Channel Inhibitors in Wild Type and NaV1.6 Gain-of-function (GOF) Mouse Seizure Control

BRITISH JOURNAL OF PHARMACOLOGYno. 20 (2024): 3993-4011

Cited1Views0WOSBibtex

Regio- and Stereoselective Ring Contraction of 1,2-Dithianes to 1,2-Dithiolanes

Tarek S. Mansour,Colleen A. Evans, David E. Bogucki,Sultan Chowdhury

Tetrahedron Letters（2023）

Cited0Views0Bibtex

Author Response: NBI-921352, a First-in-class, NaV1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of-function Mice, and Wild-Type Mice and Rats

openalex（2022）

Cited26Views0Bibtex

NBI-921352, a First-in-class, NaV1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of-function Mice, and Wild-Type Mice and Rats

ELIFE (2022)

Cited31Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn